HCQ Archives

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

30/11/2021 No Comments

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Conservative United Australia Party to Run Candidates in All Lower House Seats in 2022 Elections

25/11/2021 No Comments

Kelly, who is the current member for Hughes in New South Wales, faced a strong backlash from segments of the media and political opponents for sharing information about the anti-malaria drug hydroxychloroquine. Kelly has since appeared at freedom rallies against mandatory vaccinations.

Dr. John Littell, MD – Interview Part 2: The Florida Covid Summit

08/11/2021 No Comments

is perspective, highlights of the event, which attracted nearly 1,000 delegates, making it the largest C19 conference ever in the world.

Dr. John Littell, MD Interview – Part 1 – Perspectives on COVID Treatments, Vaccines & Policy in Florida

08/11/2021 No Comments

In this first part of our interview, Dr. John Littell, MD, tells us here about his early days in treating COVID-19 early, about his perspectives regarding vaccination, especially of children, and about the trends in COVID-19 policy in Florida.

Top Doctors Rise Up: “We’re Going to Come and Show People How to End This Pandemic”

01/11/2021 No Comments

“We have a covid protocol; it’s a standard. You cannot go outside of it,” said the long-time nurse who did not want to be named for fear of being fired. “It breaks your heart that these people have been receiving this and don’t survive, and there are alternatives that are actually available that are not being used.”

South Africa’s Tale of COVID-19, Medicine, and Vaccination – Pandemic National Case Studies

31/10/2021 No Comments

South Africa’s excess mortality trends may shed further light on the efficacy of various interventions. Upon publicly announcing its intentions to secure an HCQ supply, overall excess deaths trended negative, as is often the case following a surge as most surges in excess mortality take place among the most frail who would otherwise make up a substantial portion of those who might have died in upcoming weeks or months. However, excess deaths did not revert particularly sharply after cessation of HCQ usage or upon introduction of vaccines. Each gave way to new waves of mortality.

Dr. Peter McCullough Explains the Importance of Early Treatment

25/10/2021 No Comments

Whatever one thinks about COVID vaccines and their associated risks, it is important to understand the protocols frontline physicians have developed to treat the COVID infected, and conclude that authorities should not interfere with their prescriptions and practices–all of which have been amply studied.

Dose Dependence in the Hydroxychloroquine Prophylaxis Research – The Chloroquine Wars Part LXXIV

02/10/2021 No Comments

We should group all the PrEP, PEP, and early treatment studies of HCQ together at the point at which we see temporal and dose dependent effects time and again. Such research should certainly be separated out, but at the point at which signs of antiviral action emerge so consistently, that observation ties the body of evidence together.

Turkey’s Tale of COVID-19, Medicine, and Vaccination – Pandemic National Case Studies

01/10/2021 No Comments

The government had already taken steps to stockpile hydroxychloroquine (HCQ) in large quantity in February upon learning of China’s decision to treat with chloroquine. By March 21, Turkey made the decision to treat patients broadly with HCQ. From March 24 to April 6, Turkey saw incidences of pneumonia among COVID-19 patients plummet from just over 60% to just under 20%, indicating that HCQ likely had a strong antiviral effect in patients.

Costa Rica’s Tale of COVID-19, Medicine, and Vaccination: Pandemic National Case Studies

31/08/2021 No Comments

It does not appear that mass vaccination has yet reduced Costa Rica’s climbing COVID-19 case explosion or mounting death toll.

Vietnam’s Tale of COVID-19, Medicine, and Vaccination: Pandemic National Case Studies

29/08/2021 No Comments

TUBS, CC BY-SA 3.0 <https://creativecommons.org/licenses/by-sa/3.0>, via Wikimedia Commons Source: Rounding the Earth Author: Mathew Crawford “One worm may damage the whole cooking soup.” -Vietnamese Proverb

Demand Early Treatment! – All questions Covid with Dr. Al Johnson and Dr. Peter McCullough

21/08/2021 No Comments

The latest information about:
the Delta variant;
asymptomatic transmission and testing;
natural immunity from having a covid-19 infection vs vaccination;
what to do if you have symptoms;
testing;
the use of nutraceuticals;
treatment protocols;
the use of hydroxychloroquine and ivermectin;
putting to rest the question of hydroxychloroquine and adverse cardiological effects;
gastrointestinal symptoms of Delta;
being aware of our state of health;
oral and dental hygiene;
the use of monoclonal antibodies including Regeneron, Remdesivir and full dose blood thinners;
outpatient followup;
long hauler Covid;
myocarditis;
the commencement of early treatment;
the role of fever in the disease process;
the use of NSAIDs;
obesity as a risk factor;
talking to your physician;
the failure of vaccines.

Far-Reaching Interview with Nick Hudson from Pandemics Data & Analytics (PANDA)

12/08/2021 No Comments

This is a far reaching interview with Nick Hudson, who is the leader of PANDA, which stands for Pandemics Data & Analytics

Dr George Fareed – the Outpatient Treatment of C19

03/08/2021 No Comments

Dr George Fareed provides an update about the outpatient treatment of COVID-19, for newly infected and for long covid patients.

The Ultimate Hydroxychloroquine Treatment Data Set – The Chloroquine Wars Part XLVII

16/07/2021 No Comments

On October 8, 2019, the French Minister of Health began the process of putting HCQ on a list of poisonous substances after it was available OTC for decades without a problem. She is married to the former CEO of INSERM, which arranged the building of the first level 4 biosafety lab in mainland China, known as the Wuhan Institute of Virology. The pressure was building to bury the news of medical agents that successfully treat COVID-19 infection from a very early moment. We needed to organize early to stop that genocide.

The Meta-Analytical Fixers: An Ivermectin Tale – The Chloroquine Wars Part XL

02/07/2021 No Comments

The Roman/Hernandez meta-analysis comes at a politically contentious moment. Their language and behavior appear political. Their work is error-laden, takes research out of its true context, uses numbers that don’t seem to come from the actual studies, chooses papers testing ivermectin under the least favorable circumstances, gives unexplained and inappropriate weights to the small amount of data that stands as outliers to the bigger picture, and still drives a conclusion of “don’t use this” from a massive average mortality reduction that did not quite reach statistical significance. At the same time the authors consistently complain about the “low quality of evidence” represented by the studies they do and do not include, nearly all of which I would describe as produced by higher quality scientists who can at least tally numbers correctly.

Debating Ivermectin, Hydroxychloroquine, and Colchicine

29/06/2021 No Comments

Those who design the trials and control the data also control the outcome. So this system of industry-led trials needs to be put to an end.

Structural basis of anti-SARS-CoV-2 activity of HCQ: specific binding to N protein to disrupt its interaction with nucleic acids and LLPS

20/06/2021 No Comments

The results not only provide a structural basis for the anti-SARS-CoV-2 activity of HCQ, but also renders HCQ to be the first known drug capable of targeting LLPS.

How to Rig Research: The WHO Edition – The Chloroquine Wars Part XXXIII

14/06/2021 No Comments

Source: Rounding The Earth Author: Mathew Crawford Fifty years ago today, the New York Times began publication of the Pentagon Papers, informing the public about how a government-engineered

Weight-Adjusted Hydroxychloroquine and Azithromycin Boosted Survival of Ventilated COVID-19 Patients by 200 Percent: Study

09/06/2021 No Comments

“We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients,” the authors of the study noted.

Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting

06/04/2021 No Comments

Our investigation of a large national cohort appears to support early administration (within the first 3 to 7 days of COVID-19 diagnosis) of HCQ in mild COVID-19 disease in an outpatient setting for reducing hospitalizations and deaths without any serious adverse HCQ-related effects.
If this finding is confirmed in future clinical trials, HCQ as a cheap and available drug may still play a role in a specific population with respect to reducing COVID-19 burden, particularly in resource-poor countries.

Brazil: ‘To say that hydroxychloroquine and ivermectin kill is a fallacy’, says president of the Federal Council of Medicine

25/03/2021 No Comments

To say that hydroxychloroquine and ivermectin kill is a fallacy. Who wants to do the early treatment, do it. Whoever doesn’t want it, don’t do it

Utah authorities gave ‘green light’ to CEO accused of illegally receiving coronavirus drug, his lawyer says

14/01/2021 No Comments

A Utah pharmacist accused of illegally receiving a controversial coronavirus drug “had a green light from a lot of very prominent Utah authorities to do exactly what he did,” his defense attorney asserts.

Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

14/01/2021 No Comments

In this study of COVID-19, for infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization

“I treated Covid not caring about the bans: zero deaths. But they told me to shut up ”▷ Dr. Szumski

13/01/2021 No Comments

From my patients who are treated by me from the beginning, I have had no deaths.

Hydroxychloroquine shows potential to target autoinflammatory component of CPRS

13/01/2021 No Comments

A new Stanford study the first to show that the anti-malarial drug hydroxychloroquine (HCQ) may target the autoinflammatory component of CRPS.

Adherence to Hydroxychloroquine Lowers Lupus Mortality

07/01/2021 No Comments

A lupus cohort study from British Columbia, Canada has shown that medication adherence with hydroxychloroquine (HCQ) is associated with a 71% to 83% lower mortality.

High Hydroxychloroquine Blood Level May Lower Thrombosis Risk in Lupus

07/01/2021 No Comments

Maintaining an average hydroxychloroquine whole blood level above 1,068 ng/mL significantly reduced the risk of thrombosis in adults with systemic lupus.

The results of a meta-analysis of 187 studies treating COVID-19 successfully with hydroxychloroquine are statistically irrefutable.

05/01/2021 No Comments

HCQ is effective for COVID-19. The chance that an ineffective treatment generated results as positive as the 187 studies to date is 1 in 5 quadrillion (p = 0.00000000000000019).

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.

04/01/2021 No Comments

Hydroxychloroquine is an effective molecule against COVID-19 infection, many RCTs and observational studies, affirmed the benefits on virological clearance.

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19

04/01/2021 No Comments

No cases of sudden death were observed. From publication, we have treated 3,119 patients with HCQ-AZ for at least three days.

Unimed do Pará: “55,000 patients treated with hydroxy/chloroquine”

03/01/2021 No Comments

From there, we had an abrupt drop in our curve… we did more than 50,000 treatments… after we started the treatment early, we had no more than 5% hospitalization

Dr. Simone Gold talks about COVID19, the lies and deception, the vaccine, and hydroxychloroquine.

03/01/2021 No Comments

It is impossible to say that a drug with an extensively documented and strong safety record for 65 years is dangerous but a brand new medication is safe.

BENGAL’S MANAGEMENT PROTOCOL FOR COVID-19 INCLUDES HCQ

28/12/2020 No Comments

Bengal has released this document to state their COVID-19 policies, which include the use of HCQ. Well done Bengal.

Germany: 4 times fewer deaths than in France thanks to hydroxychloroquine

25/12/2020 No Comments

While Professor Raoult was testing, isolating and treating his patients, the government decided to send the patients home, without care and with Doliprane for only treatment!

Hydroxychloroquine factory on fire after explosion: Taiwan

20/12/2020 No Comments

The pharmaceutical factory produces hydroxychloroquine APIs, and is the world’s second largest HCQ raw material supplier.

Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation; the experience from Shanghai, China

18/12/2020 No Comments

The early use of
hydroxychloroquine decreased the improvement time
and the duration of COVID-19 detection in throat and
stool swabs.

Tag: HCQ

Copyright 2020 © The Palmer Foundation